REGN vs RR · P/E 14, rev $14.34B vs rev $5.0M
Regeneron Pharmaceuticals Inc (REGN) versus Richtech Robotics Inc. Class B Common Stock (RR) — a side-by-side from cached financials, not a winner call.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Richtech Robotics Inc. Class B Common Stock (RR) is a specialty industrial machinery company listed on US.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Latest reported RR revenue for 2025-09-30 was $5.0M. Net income was -$15.8M. Revenue was up 19.0% from 2024-09-30 to 2025-09-30. RR currently screens at market cap $225.0M.
REGN currently screens at market cap $59.10B and trailing P/E 13.9. RR currently screens at market cap $225.0M.
Not investment advice. Open the REGN and RR stock pages for the full models.
Not investment advice.